Phillip Pang, Chief Medical Officer at Vir Biotechnology, Inc. (VIR), sold 17,759 shares at $24.89 ($248K) on 2022-06-21, disclosed to the SEC on 2022-06-22.
Open-market sale of $248k VIR by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 7,777 | $0 | 0.0% |
| 2 | $24.89 | 4,991 | $124K | 50.0% |
| 3 | $24.89 | 4,991 | $124K | 50.0% |
| Total | $13.99 avg | 17,759 | $248K | 100% |
| Filing → |
| VIR | SELL | 2023-06-08 | $130K | — | Filing → |
| VIR | SELL | 2023-02-28 | $238K | — | Filing → |
| VIR | SELL | 2023-02-24 | $149K | — | Filing → |